Cell cycle-related genes as modifiers of age of onset of colorectal cancer in lynch syndrome: A large-scale study in non-Hispanic white patients

Carcinogenesis

Volumn 34, Issue 2, 2013, Pages 299-306

  Chen, Jinyun ^a   Pande, Mala ^a   Huang, Yu Jing ^a   Wei, Chongjuan ^a   Amos, Christopher I ^a   Talseth Palmer, Bente A ^b,c   Meldrum, Cliff J ^d   Chen, Wei V ^a   Gorlov, Ivan P ^a   Lynch, Patrick M ^a   Scott, Rodney J ^b,d   Frazier, Marsha L ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^d JOHN HUNTER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RISK; CANCER SURVIVAL; CAUCASIAN; CELL CYCLE REGULATION; COLORECTAL CANCER; CONTROLLED STUDY; DNA REPAIR; FEMALE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENOTYPE; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HIGH RISK POPULATION; HUMAN; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; CELL CYCLE PROTEINS; COLORECTAL NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS; TEXAS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84873544856     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs344     Document Type: Article

References (73)

1. Edelmann,L. et al. (2004) Loss of DNA mismatch repair function and cancer predisposition in the mouse: animal models for human hereditary nonpolyposis colorectal cancer. Am. J. Med. Genet. C. Semin. Med. Genet., 129C, 91-99.
2. Nakagawa,H. et al. (2004) Mismatch repair gene PMS2: disease-causing germline mutations are frequent in patients whose tumors stain negative for PMS2 protein, but paralogous genes obscure mutation detection and interpretation. Cancer Res., 64, 4721-4727.
3. Peltomäki,P. et al. (2004) Mutations associated with HNPCC predisposition - Update of ICG-HNPCC/INSiGHT mutation database. Dis. Markers, 20, 269-276.
4. Worthley,D.L. et al. (2005) Familial mutations in PMS2 can cause autosomal dominant hereditary nonpolyposis colorectal cancer. Gastroenterology, 128, 1431-1436.
5. Kovacs,M.E. et al. (2009) Deletions removing the last exon of TACSTD1 constitute a distinct class of mutations predisposing to Lynch syndrome. Hum. Mutat., 30, 197-203.
6. Ligtenberg,M.J. et al. (2009) Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1. Nat. Genet., 41, 112-117.
7. Lynch,H.T. et al. (1991) Hereditary nonpolyposis colorectal cancer (Lynch syndromes I & II). Genetics, pathology, natural history, and cancer control, Part I. Cancer Genet. Cytogenet., 53, 143-160.
8. Mecklin,J.P. et al. (1991) Tumor spectrum in cancer family syndrome (hereditary nonpolyposis colorectal cancer). Cancer, 68, 1109-1112.
9. Boland,C.R. et al. (1998) A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res., 58, 5248-5257.
10. Rodriguez-Bigas,M.A. et al. (1997) A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J. Natl Cancer Inst., 89, 1758-1762.
11. Umar,A. et al. (2004) Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J. Natl Cancer Inst., 96, 261-268.
12. Hendriks,Y.M. et al. (2004) Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. Gastroenterology, 127, 17-25.
13. Plaschke,J. et al. (2004) Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium. J. Clin. Oncol., 22, 4486-4494.
14. Elledge,S.J. (1996) Cell cycle checkpoints: preventing an identity crisis. Science, 274, 1664-1672.
15. Chen,J. et al. (2007) Association between Aurora-A kinase polymorphisms and age of onset of hereditary nonpolyposis colorectal cancer in a Caucasian population. Mol. Carcinog., 46, 249-256.
16. Jones,J.S. et al. (2004) p53 polymorphism and age of onset of hereditary nonpolyposis colorectal cancer in a Caucasian population. Clin. Cancer Res., 10, 5845-5849.
17. Kong,S. et al. (2000) Effects of cyclin D1 polymorphism on age of onset of hereditary nonpolyposis colorectal cancer. Cancer Res., 60, 249-252.
18. Zheng,Y. et al. (2002) Haplotypes of two variants in p16 (CDKN2/MTS-1/ INK4a) exon 3 and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Epidemiol. Biomarkers Prev., 11, 640-645.
19. Starinsky,S. et al. (2005) Genotype phenotype correlations in Israeli colorectal cancer patients. Int. J. Cancer, 114, 58-73.
20. Li,G. et al. (2004) Association between the V109G polymorphism of the p27 gene and the risk and progression of oral squamous cell carcinoma. Clin. Cancer Res., 10(12 Pt 1), 3996-4002.
21. Simon,M. et al. (2006) Variant of the CHEK2 gene as a prognostic marker in glioblastoma multiforme. Neurosurgery, 59, 1078-1085.
22. Yue,P. et al. (2006) SNPs3D: candidate gene and SNP selection for association studies. BMC Bioinformatics, 7, 166.
23. De La Vega,FM. et al. (2006) A tool for selecting SNPs for association studies based on observed linkage disequilibrium patterns. Pac. Symp. Biocomput., 487-498.
24. Lee,P.H. et al. (2009) An integrative scoring system for ranking SNPs by their potential deleterious effects. Bioinformatics, 25, 1048-1055.
25. Kent,W.J. et al. (2002) The human genome browser at UCSC. Genome Res., 12, 996-1006.
26. Rosenbloom,K.R. et al. (2010) ENCODE whole-genome data in the UCSC Genome Browser. Nucleic Acids Res., 38, D620-D625.
27. Bernstein,B.E. et al. (2012) An integrated encyclopedia of DNA elements in the human genome. Nature, 489, 57-74.
28. Williams,R.L. (2000) A note on robust variance estimation for cluster-correlated data. Biometrics, 56, 645-646.
29. Benjamini,Y. et al. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. Roy. Stat. Soc., 57, 289-300.
30. Barrett,J.C. et al. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics, 21, 263-265.
31. Han,J. et al. (2004) Polymorphisms in DNA double-strand break repair genes and skin cancer risk. Cancer Res., 64, 3009-3013.
32. Popanda,O. et al. (2004) Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis, 25, 2433-2441.
33. Wu,X. et al. (2006) Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am. J. Hum. Genet., 78, 464-479.
34. Lin,D. et al. (1989) The robust inference for the Cox proportional hazards model. J. Am. Stat. Assoc., 84, 1074-1078.
35. Hayden,P.J. et al. (2007) Variation in DNA repair genes XRCC3, XRCC4, XRCC5 and susceptibility to myeloma. Hum. Mol. Genet., 16, 3117-3127.
36. MassaguéJ. (2008) TGFbeta in Cancer. Cell, 134, 215-230.
37. Stankovic,T. et al. (1999) Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia. Lancet, 353, 26-29.
38. Webb,E.L. et al. (2006) Search for low penetrance alleles for colorectal cancer through a scan of 1467 non-synonymous SNPs in 2575 cases and 2707 controls with validation by kin-cohort analysis of 14 704 first-degree relatives. Hum. Mol. Genet., 15, 3263-3271.
39. Crawford,G.E. et al. (2006) Genome-wide mapping of DNase hypersensitive sites using massively parallel signature sequencing (MPSS). Genome Res., 16, 123-131.
40. Michl,P. et al. (2005) CUTL1 is a target of TGF(beta) signaling that enhances cancer cell motility and invasiveness. Cancer Cell, 7, 521-532.
41. van Wijnen,A.J. et al. (1996) CDP/cut is the DNA-binding subunit of histone gene transcription factor HiNF-D: a mechanism for gene regulation at the G1/S phase cell cycle transition point independent of transcription factor E2F. Proc. Natl Acad. Sci. U.S.A., 93, 11516-11521.
42. Sharma,S. et al. (2011) Association of variants in innate immune genes with asthma and eczema. Pediatr. Allergy Immunol., 23, 315-323.
43. Angèle,S. et al. (2004) ATM polymorphisms as risk factors for prostate cancer development. Br. J. Cancer, 91, 783-787.
44. Cesaretti,J.A. et al. (2005) ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys., 61, 196-202.
45. Gutiérrez-Enríquez,S. et al. (2004) Functional consequences of ATM sequence variants for chromosomal radiosensitivity. Genes. Chromosomes Cancer, 40, 109-119.
46. Larson,G.P. et al. (1997) An allelic variant at the ATM locus is implicated in breast cancer susceptibility. Genet. Test., 1, 165-170.
47. Meyer,A. et al. (2007) ATM missense variant P1054R predisposes to prostate cancer. Radiother. Oncol., 83, 283-288.
48. Schreiber,A. et al. (2011) Structural basis for the subunit assembly of the anaphase-promoting complex. Nature, 470, 227-232.
49. Wang,Q. et al. (2003) Alterations of anaphase-promoting complex genes in human colon cancer cells. Oncogene, 22, 1486-1490.
50. Chatzaki,E. et al. (2003) Transforming growth factor beta1 exerts an autocrine regulatory effect on human endometrial stromal cell apoptosis, involving the FasL and Bcl-2 apoptotic pathways. Mol. Hum. Reprod., 9, 91-95.
51. Katayama,N. et al. (2000) Bcl-2 in cell-cycle regulation of hematopoietic cells by transforming growth factor-beta1. Leuk. Lymphoma, 39, 601-605.
52. Scolnick,D.M. et al. (2000) Chfr defines a mitotic stress checkpoint that delays entry into metaphase. Nature, 406, 430-435.
53. Cai,Z. et al. (1997) Resistance of MCF7 human breast carcinoma cells to TNF-induced cell death is associated with loss of p53 function. Oncogene, 15, 2817-2826.
54. Hu,X. et al. (2002) Ubiquitin/proteasome-dependent degradation of D-type cyclins is linked to tumor necrosis factor-induced cell cycle arrest. J. Biol. Chem., 277, 16528-16537.
55. Chen,Y. et al. (2012) Time-course network analysis reveals TNF-α can promote G1/S transition of cell cycle in vascular endothelial cells. Bioinformatics, 28, 1-4.
56. Kong,S. et al. (2001) Cyclin D1 polymorphism and increased risk of colorectal cancer at young age. J. Natl Cancer Inst., 93, 1106-1108.
57. Lewis,R.C. et al. (2003) Polymorphism of the cyclin D1 gene, CCND1, and risk for incident sporadic colorectal adenomas. Cancer Res., 63, 8549-8553.
58. Huang,W.S. et al. (2006) Impact of the cyclin D1 A870G polymorphism on susceptibility to sporadic colorectal cancer in Taiwan. Dis. Colon Rectum, 49, 602-608.
59. Dunlop,M.G. et al. (2012) Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk. Nat. Genet., 44, 770-776.
60. Houlston,R.S. et al. (2008) Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat. Genet., 40, 1426-1435.
61. Houlston,R.S. et al. (2010) Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33. Nat. Genet., 42, 973-977.
62. Tenesa,A. et al. (2009) New insights into the aetiology of colorectal cancer from genome-wide association studies. Nat. Rev. Genet., 10, 353-358.
63. Diergaarde,B. et al. (2007) Environmental factors and colorectal tumor risk in individuals with hereditary nonpolyposis colorectal cancer. Clin. Gastroenterol. Hepatol., 5, 736-742.
64. Pande,M. et al. (2010) Smoking and colorectal cancer in Lynch syndrome: results from the Colon Cancer Family Registry and the University of Texas M.D. Anderson Cancer Center. Clin. Cancer Res., 16, 1331-1339.
65. Watson,P. et al. (2004) Tobacco use and increased colorectal cancer risk in patients with hereditary nonpolyposis colorectal cancer (Lynch syndrome). Arch. Intern. Med., 164, 2429-2431.
66. Voskuil,D.W. et al. (2002) Meat consumption and meat preparation in relation to colorectal adenomas among sporadic and HNPCC family patients in The Netherlands. Eur. J. Cancer, 38, 2300-2308.
67. Botma,A. et al. (2010) Body mass index increases risk of colorectal adenomas in men with Lynch syndrome: the GEOLynch cohort study. J. Clin. Oncol., 28, 4346-4353.
68. Campbell,P.T. et al. (2010) Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status. J. Natl Cancer Inst., 102, 391-400.
69. Blokhuis,M.M. et al. (2010) Lynch syndrome: the influence of environmental factors on extracolonic cancer risk in hMLH1 c.C1528T mutation carriers and their mutation-negative sisters. Fam. Cancer, 9, 357-363.
70. Curtin,K. et al. (2009) Meta association of colorectal cancer confirms risk alleles at 8q24 and 18q21. Cancer Epidemiol. Biomarkers Prev., 18, 616-621.
71. Pittman,A.M. et al. (2008) Refinement of the basis and impact of common 11q23.1 variation to the risk of developing colorectal cancer. Hum. Mol. Genet., 17, 3720-3727.
72. Tenesa,A. et al. (2008) Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nat. Genet., 40, 631-637.
73. Broderick,P. et al. (2007) A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk. Nat. Genet., 39, 1315-1317.